Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$445M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$354M |
| 3 |
Electronic Arts
EA
|
+$337M |
| 4 |
Procter & Gamble
PG
|
+$249M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$205M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$351M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$344M |
| 3 |
Eli Lilly
LLY
|
+$310M |
| 4 |
Hershey
HSY
|
+$308M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$280M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.03% |
| 2 | Healthcare | 12.58% |
| 3 | Financials | 11.51% |
| 4 | Industrials | 8.61% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
| $4.54M | ﹤0.01% |
49,534
-14,917
| -23% | -$1.56M |
|
|
RVNC
2227
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.54M | ﹤0.01% |
168,062
+24,797
| +17% | +$503K |
|
2228
Agios Pharmaceuticals
AGIO
$1.79B
| $4.53M | ﹤0.01% |
+160,077
| New | +$4.29M |
|
2229
Riverview Bancorp
RVSB
$107M
| $4.51M | ﹤0.01% |
710,885
+69,923
| +11% | +$480K |
|
|
ECHO
2230
EchoStar
ECHO
$24.4B
| $4.51M | ﹤0.01% |
273,837
-26,705
| -9% | -$499K |
|
2231
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$131M
| $4.5M | ﹤0.01% |
91,482
-70,819
| -44% | -$2.41M |
|
|
PRO
2232
DELISTED
PROS Holdings
PRO
| $4.5M | ﹤0.01% |
182,092
-6,655
| -4% | -$161K |
|
2233
Core Laboratories
CLB
$488M
| $4.5M | ﹤0.01% |
333,464
-29,278
| -8% | -$493K |
|
2234
Global Net Lease
GNL
$1.84B
| $4.49M | ﹤0.01% |
421,847
-18,440
| -4% | -$257K |
|
2235
OrthoPediatrics
KIDS
$519M
| $4.49M | ﹤0.01% |
97,318
-6,146
| -6% | -$301K |
|
2236
Nelnet
NNI
$4.88B
| $4.48M | ﹤0.01% |
56,535
-19,204
| -25% | -$1.67M |
|
2237
Grid Dynamics Holdings
GDYN
$559M
| $4.46M | ﹤0.01% |
238,429
-14,419
| -6% | -$273K |
|
2238
iShares MSCI Denmark ETF
EDEN
$204M
| $4.46M | ﹤0.01% |
59,986
-3,885
| -6% | -$335K |
|
2239
Agilysys
AGYS
$2.97B
| $4.46M | ﹤0.01% |
80,521
-1,944
| -2% | -$98K |
|
2240
Tradeweb Markets
TW
$21.4B
| $4.46M | ﹤0.01% |
78,976
-4,187
| -5% | -$285K |
|
2241
St. Joe Company
JOE
$3.54B
| $4.45M | ﹤0.01% |
138,875
-1,436
| -1% | -$55.7K |
|
|
BHVN
2242
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.44M | ﹤0.01% |
29,388
-20,501
| -41% | -$3.04M |
|
2243
Global X US Preferred ETF
PFFD
$2.15B
| $4.43M | ﹤0.01% |
215,033
+3,639
| +2% | +$78.7K |
|
2244
Entegris
ENTG
$18.1B
| $4.43M | ﹤0.01% |
53,320
+6,692
| +14% | +$653K |
|
2245
Suncor Energy
SU
$79.4B
| $4.42M | ﹤0.01% |
154,097
+76,047
| +97% | +$2.4M |
|
2246
Integra LifeSciences
IART
$1.29B
| $4.41M | ﹤0.01% |
104,015
-4,505
| -4% | -$231K |
|
2247
3D Systems Corp
DDD
$431M
| $4.41M | ﹤0.01% |
551,888
-997
| -0.2% | -$10.2K |
|
2248
Bank of Hawaii
BOH
$3.15B
| $4.4M | ﹤0.01% |
57,849
-2,684
| -4% | -$211K |
|
2249
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $4.4M | ﹤0.01% |
185,005
+80,762
| +77% | +$2.01M |
|
2250
Bank of Montreal
BMO
$126B
| $4.38M | ﹤0.01% |
49,996
+16,903
| +51% | +$1.63M |
|
Similar funds
Ameriprise's Q3 2022 Portfolio in Review
As of Q3 2022, Ameriprise held 4,097 positions worth $270B, down 5.7% from $287B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q3 2022 filing shows 218 new, 1,662 increased, 1,949 reduced and 144 closed positions. Its largest new stake was Pacer Lunt Large Cap Alternator ETF: 652,979 shares worth $23.4M. The largest sale was RTX Corp, an estimated $351M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q3 2022 buy was Pacer Lunt Large Cap Alternator ETF: 652,979 shares worth $23.4M.
- Ameriprise added most to Microchip Technology in Q3 2022, an estimated $445M increase.
- Ameriprise's biggest Q3 2022 reduction was RTX Corp, cutting an estimated $351M.
- Ameriprise fully exited VanEck Emerging Markets High Yield Bond ETF in Q3 2022, selling an estimated $49.5M.
- Ameriprise's ten largest holdings make up 14% of its $270B portfolio in Q3 2022.
- Ameriprise opened 218 new positions and closed 144 in Q3 2022.
- Ameriprise's portfolio value fell 5.7% quarter-over-quarter to $270B.
Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.